About the Company
We do not have any company description for Liminatus Pharma, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Liminatus Pharma, Inc.
Liminatus Pharma Inc. Evaluates Formation of Digital Asset ... - WWLP
LA PALMA, Calif., July 25, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer ...
Liminatus Pharma Updates on CD47 Inhibitor IBA101
Liminatus Pharma ( ($LIMN) ) has provided an announcement. On August 14, 2025, Liminatus Pharma announced an update on its CD47 checkpoint ...
Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary ...
LA PALMA, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer ...
Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain ...
LA PALMA, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer ...
Liminatus Pharma Inc. to Launch “American BNB Strategy” Subsidiary and Target Up To $500 Million Fund for BNB Investment as Part of Crypto Market Initiative
Detailed price information for Liminatus Pharma Inc Cl A (LIMN-Q) from The Globe and Mail including charting and trades.
Liminatus Pharma Inc. Wt (LIMNW) Stock Price Today - WSJ
View the latest Liminatus Pharma Inc. Wt (LIMNW) stock price, news, historical charts, analyst ratings and financial information from WSJ.
LIMNW Liminatus Pharma, Inc. WT EXP 043030 - Seeking Alpha
Liminatus Pharma, Inc. WT EXP 043030 (LIMNW) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions ...
Liminatus Pharma, Inc. (LIMN) Stock Competitors & Similar Stocks ...
Liminatus Pharma, Inc. (LIMN) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.
Liminatus Pharma Inc. Evaluates Formation of Digital Asset Investment ...
LA PALMA, Calif., July 25, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted cancer ...
Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain ...
Liminatus Pharma, Inc. Initiates Strategic Review of Blockchain-Integrated Treasury Strategy Provided by GlobeNewswire Jul 22, 2025, 10:30:00 AM ...
Similar Companies
Loading the latest forecasts...